List of SBIR/STTR awards granted to Radikal Therapeutics
Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase II contract was awarded to Radikal Therapeutics in April, 2015 for $1,500,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44HD082865-01 | Phase II | 1,500,000 | April 1, 2015 | |||||||
A SBIR Phase II contract was awarded to Radikal Therapeutics in September, 2016 for $2,443,579.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44GM100503-02A1 | Phase II | 2,443,579 | September 1, 2016 | |||||||
A SBIR Phase II contract was awarded to Radikal Therapeutics in September, 2016 for $1,500,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44AR070686-01 | Phase II | 1,500,000 | September 1, 2016 | |||||||
A SBIR Phase II contract was awarded to Radikal Therapeutics in September, 2017 for $1,499,461.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44AR065886-02A1 | Phase II | 1,499,461 | September 22, 2017 | |||||||
A SBIR Phase II contract was awarded to Radikal Therapeutics in April, 2017 for $1,468,688.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44GM122095-01 | Phase II | 1,468,688 | April 3, 2017 | |||||||
A SBIR Phase I contract was awarded to Radikal Therapeutics for $245,133.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43DK097843-01 | Phase I | 245,133 | ||||||||
A SBIR Phase I contract was awarded to Radikal Therapeutics for $237,906.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43HL110374-01 | Phase I | 237,906 | ||||||||
A SBIR Phase I contract was awarded to Radikal Therapeutics for $222,371.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI098146-01A1 | Phase I | 222,371 | ||||||||
A SBIR Phase I contract was awarded to Radikal Therapeutics for $225,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AR065886-01A1 | Phase I | 225,000 | ||||||||
A SBIR Phase I contract was awarded to Radikal Therapeutics for $252,296.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43GM100503-01 | Phase I | 252,296 | ||||||||
A SBIR Phase II contract was awarded to Radikal Therapeutics for $1,527,261.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44DK091972-02 | Phase II | 1,527,261 | ||||||||
A SBIR Phase I contract was awarded to Radikal Therapeutics for $296,339.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43HL117386-01 | Phase I | 296,339 | ||||||||
A SBIR Phase I contract was awarded to Radikal Therapeutics for $298,327.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AR062372-01A1 | Phase I | 298,327 | ||||||||
A SBIR Phase I contract was awarded to Radikal Therapeutics for $263,034.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI092832-01 | Phase I | 263,034 | ||||||||
A SBIR Phase I contract was awarded to Radikal Therapeutics for $390,713.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43HL115843-01 | Phase I | 390,713 | ||||||||
A SBIR Phase I contract was awarded to Radikal Therapeutics for $225,919.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43EY024806-01 | Phase I | 225,919 | ||||||||
A SBIR Phase I contract was awarded to Radikal Therapeutics for $254,413.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43DK091972-01A1 | Phase I | 254,413 | ||||||||
A SBIR Phase I contract was awarded to Radikal Therapeutics for $231,477.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43NS081799-01A1 | Phase I | 231,477 | ||||||||
A SBIR Phase I contract was awarded to Radikal Therapeutics for $260,513.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43DK093168-01A1 | Phase I | 260,513 | ||||||||
A SBIR Phase I contract was awarded to Radikal Therapeutics for $256,638.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43NS074546-01A1 | Phase I | 256,638 | ||||||||
A SBIR Phase II contract was awarded to Radikal Therapeutics for $2,163,046.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44HL108370-02 | Phase II | 2,163,046 | ||||||||
A SBIR Phase I contract was awarded to Radikal Therapeutics for $625,465.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43NS076002-01 | Phase I | 625,465 | ||||||||
A SBIR Phase I contract was awarded to Radikal Therapeutics for $220,613.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43EY021379-01 | Phase I | 220,613 | ||||||||
A SBIR Phase I contract was awarded to Radikal Therapeutics for $240,508.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43HL112341-01 | Phase I | 240,508 | ||||||||
A SBIR Phase I contract was awarded to Radikal Therapeutics for $249,465.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43HL108382-01A1 | Phase I | 249,465 |
